Frontlight ResearchEarly access
Trial site
Retina Group of New England
- 7running trials
- 6closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Macular degeneration9 trials
- Diabetic eye disease5 trials
- Phase
- Phase 39 trials
- Phase 2/32 trials
- Phase 1/21 trial
- Phase 21 trial
- Status
- Completed5 trials
- Recruiting4 trials
- Active, not recruiting3 trials
- Terminated1 trial
- Lead sponsor
- Hoffmann-La Roche4 trials
- Ocular Therapeutix, Inc.2 trials
- Regeneron Pharmaceuticals2 trials
- Amgen1 trial
- EyeBiotech Ltd.1 trial
- and 3 more
Running trials
Recruiting
Recruiting
Recruiting
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
Recruiting
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Macular degeneration4 recruiting
Closed trials
Recruiting
Completed
Completed
Completed
Completed
Recruiting
Extension Study for the Port Delivery System With Ranibizumab (Portal)
Site data: ClinicalTrials.govUpdated 18 Nov 2026